| Sponsor | | | Type | StatusCT | | CTSU/IBCSG | IBCSG-25-02 | Exemestane, GnRH Analogue (TEXT) | Breast | Open | | SWOG | Map.3 | Ca Control: Exemestane/Placebo in High Risk | Breast | Open | | SWOG | S0221 | Paclitaxel | Breast | Open | | SWOG | S0226 | Anastrozole, fulvestrant | Breast | Open | | SWOG | S0430 | Cyclophosphamide/Capecitabine | Breast | Open | | SWOG | S0307 | Bisphosphonates Breast | Breast | Open | | SWOG | S0500 | Tx per Circulating Tumor Cells | Breast | Open | SWOG/CTSU/
ECOG | PACCT-1 | Individualized treatment | Breast | Open | | SWOG | C80405 | Bevacizumab, Cetuximab | GI- Colon | Open | | SWOG | S0356 | Oxaliplatin/5FU | GI-Esophageal | Open | | SWOG | S0425 | Neoadjuvant chemoradiation: cisplatin/capecitabine | GI-Gastric | Open | | SWOG/CTUS | E5202 | Leucovorin + 5-FU, Oxaliplatin, Bevacizumab | GI-Colon | Open | | SWOG | S0421 | Docetaxel, Atrasentan | GI-Prostate | Open | | SWOG | S9346 | Casodex®, Goserelin acetate | GU-prostate | Open | | SWOG | S9007 | Cytogenetics | Heme-Leukemia | Open | | SWOG | S8819 | Spec. Repository | Heme-Lymphoma | Open | | SWOG | S8947 | Spec. Repository | Heme-Lymphoma | Open | | SWOG | S0220 | RT, Cisplatin, VP-16, Surgery, Docetaxel | Lung | Closed | | SWOG | S0424 | Molecular Epidemiology Case-Series Study | Lung | Open | | SWOG | S0509 | AZD2171 | Lung | Open | | SWOG | S0533 | Bevacizumab, Cisplatin, Docetaxel, Etoposide, RT | Lung | Open | | SWOG | S0429 | Cetuximab, Docetaxel, Radiation Therapy | Lung | Open | | SWOG | S0435 | BAY 43-9006 | Lung | Open | | SWOG | S9925 | Spec. Repository | Lung | Open | | SWOG | S0512 | BAY 43-9006 | Melanoma | Open | | SWOG | S0505 | BAY 43-9006 | Sarcoma | Open |
SWOG = Southwest Oncology Group
CTSU = Cancer Trials Support Unit
CALGB = Cancer and Acute Leukemia Group B
ECOG = Eastern Cooperative Oncology Group
NSABP = National Surgical Adjuvant Breast and Bowel Project
Click here to go back to the Main Clinical Trials Page
Clinical Trial List
|
Radiation Oncology
